PharmaCyte Biotech to Hold Shareholder Call
Jan 18, 2017 14:01 pm UTC| Business
LAGUNA HILLS, Calif., Jan. 18, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell...
Jan 18, 2017 14:01 pm UTC| Business
NEW YORK, Jan. 18, 2017 -- Hunt Mortgage Partners, LLC, a wholly owned subsidiary of Hunt Mortgage Group and a leader in financing commercial real estate throughout the United States, today announced it provided...
Jan 18, 2017 14:01 pm UTC| Business
NEW YORK, Jan. 18, 2017 -- Hunt Mortgage Partners, LLC, a wholly owned subsidiary of Hunt Mortgage Group and a leader in financing commercial real estate throughout the United States, today announced it provided...
AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing Gum
Jan 18, 2017 14:01 pm UTC| Business
NEW YORK, Jan. 18, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, entered a clinical trial on treating irritable bowel syndrome (IBS) with the...
AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing Gum
Jan 18, 2017 14:01 pm UTC| Business
NEW YORK, Jan. 18, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, entered a clinical trial on treating irritable bowel syndrome (IBS) with the...
Jan 18, 2017 14:01 pm UTC| Business
MALVERN, Pa., Jan. 18, 2017 -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biopolymer-based drugs for the treatment of orphan diseases with an initial focus on cardiopulmonary...
Jan 18, 2017 14:01 pm UTC| Business
MALVERN, Pa., Jan. 18, 2017 -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biopolymer-based drugs for the treatment of orphan diseases with an initial focus on cardiopulmonary...